Can early serum lipase measurement be routinely implemented to rule out clinically significant pancreatic fistula after pancreaticoduodenectomy

Published on Sep 1, 2015in International Journal of Surgery
· DOI :10.1016/j.ijsu.2015.04.090
Raffaele Dalla Valle7
Estimated H-index: 7
Mario De Bellis1
Estimated H-index: 1
+ 4 AuthorsMaurizio Iaria4
Estimated H-index: 4
Abstract Introduction Postoperative pancreatic fistula (POPF) is the most significant cause of morbidity and mortality after pancreaticoduodenectomy (PD). We evaluated the role of postoperative serum lipase concentration in ruling out POPF in the immediate post-operative period. Materials and methods We retrospectively analysed 98 consecutive PD performed between January 2009 and December 2014, investigating the correlation between postoperative day 1 (POD1) serum lipase concentration and POPF development. Results 29 patients (29.5%) developed POPF [grade A, 17 (17.3%); grade B, 8 (8.1%); grade C, 4 (4%)]. A receiver operating characteristic (ROC) analysis was conducted to determine the threshold value of POD1 serum lipase associated with clinically significant POPF (AUC = 0.76, 95% CI 0.64–0.86, P = 0.01). Such threshold was ≤44.5 U/L and its sensitivity and specificity were 92% and 66%, respectively. The positive and negative predictive values (PPV, NPV) were 31% and 98%, respectively. Conclusion Early routinely measurement of serum lipase proved to be helpful in ruling out clinically relevant POPF (CR-POPF). In our cohort, a POD1 cut-off of ≤44.5 U/L allowed early and accurate identification of patients with low probability to develop clinically significant POPF, who can eventually be selected for enhanced post-operative recovery with significant clinical and economic benefits.
  • References (21)
  • Citations (4)
#1Christina W. Lee (UW: University of Wisconsin-Madison)H-Index: 3
#2Henry A. Pitt (TU: Temple University)H-Index: 55
Last.Sharon M. Weber (UW: University of Wisconsin-Madison)H-Index: 36
view all 10 authors...
#1Lavanniya Kumar Palani Velu (Glas.: University of Glasgow)H-Index: 4
#2Vishnu V. Chandrabalan (Glas.: University of Glasgow)H-Index: 2
Last.Euan J. Dickson (Glasgow Royal Infirmary)H-Index: 14
view all 8 authors...
#1Jacqueline S. Israel (UW: University of Wisconsin-Madison)H-Index: 5
#2Robert J. Rettammel (UW: University of Wisconsin-Madison)H-Index: 9
Last.Sharon M. Weber (UW: University of Wisconsin-Madison)H-Index: 36
view all 7 authors...
#1O. Facy (French Institute of Health and Medical Research)H-Index: 5
#2Claire ChalumeauH-Index: 3
Last.Pablo Ortega-Deballon (French Institute of Health and Medical Research)H-Index: 15
view all 6 authors...
Cited By4
#1F. Jasmijn Smits (UU: Utrecht University)H-Index: 3
#2Quintus Molenaar (UU: Utrecht University)H-Index: 25
Last.Hjalmar C. van Santvoort (UU: Utrecht University)H-Index: 37
view all 7 authors...
View next paperClinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma